# Oncolytics Biotech (ONCY) — News

ONCY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/oncy/news

## Recent headlines

- [INEOS Energy $700M 5NC2 notes 9.25% area](https://www.ainvest.com/news/ineos-energy-700m-5nc2-notes-9-25-area-2610) — AInvest Wire, Oct 14, 2026
  INEOS Holdings Limited has announced the launch of a new offering of senior secured notes, reflecting the company’s ongoing efforts to manage its debt structure and optimize financial flexibility. The offering, led by its wholly owned subsidiary INEOS Finance plc, involves euro-denominated senior…
- [Select Water Solutions $800M 8NC3 notes 7.5% to 7.75% range](https://www.ainvest.com/news/select-water-solutions-800m-8nc3-notes-7-5-7-75-range-2610) — AInvest Wire, Oct 14, 2026
- [Oncolytics Biotech - To receive final Pancan grant payment later this Qtr](https://www.ainvest.com/news/oncolytics-biotech-receive-final-pancan-grant-payment-qtr-2610) — AInvest Wire, Oct 14, 2026
- [Oncolytics Biotech - New method of use patents expected to provide protection into late 2040s](https://www.ainvest.com/news/oncolytics-biotech-method-patents-expected-provide-protection-late-2040s-2610) — AInvest Wire, Oct 12, 2026
  Oncolytics Biotech has recently secured a series of new method of use patents, which are expected to extend its intellectual property protection into the late 2040s. These patents cover novel therapeutic applications of the company’s lead product candidate, extending the potential commercial…
- [Oncolytics Biotech - Three patent applications pending; one to be converted to track one this quarter](https://www.ainvest.com/news/oncolytics-biotech-patent-applications-pending-converted-track-quarter-2610) — AInvest Wire, Oct 12, 2026
  Oncolytics Biotech Inc. (TSX: ONCY) has disclosed that it currently has three patent applications pending, with one of these converted to track one status during the current quarter. The company recently announced that the United States Patent and Trademark Office has issued new patent protecting…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).